New dressing combo aims to soothe anal pain during rectal cancer radiation

NCT ID NCT06837831

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special dressing (Mepilex Lite) placed inside the anal canal, combined with a pain-relieving suppository (indomethacin), can better treat acute radiation dermatitis—painful, red, or ulcerated skin—caused by radiotherapy for rectal cancer. About 274 adults who develop at least grade 2 radiation burns will be split into two groups: one gets routine care plus the suppository, the other gets the same plus the dressing. Researchers will check skin healing and pain levels at 7, 14, and 21 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mepilex Lite dressing and indomethacin suppository
What this could lead to
If it works, this could offer a more effective way to manage painful radiation burns in the anal area, improving comfort and quality of life during rectal cancer treatment.
What could go wrong
This is a single-center trial with a moderate number of participants. The dressing insertion itself can be painful, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RADIATION DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Shandong First Medical University

    RECRUITING

    Jinan, Shandong, 250000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.